BiotechTube

Diclofenac sodium 1mg/g

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Sunburn

Conditions

Sunburn

Trial Timeline

Nov 1, 2006 → Dec 1, 2006

NCT ID
NCT00441051

About Diclofenac sodium 1mg/g

Diclofenac sodium 1mg/g is a phase 3 stage product being developed by Novartis for Sunburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00441051. Target conditions include Sunburn.

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00441051Phase 3Completed